TickerFactsScreenerDevelopers

Karyopharm Therapeutics Inc. (KPTI) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $376.0K2012: $121.0K2013: $57.0K2014: $2.83M2015: $1.42M2016: $70.0K2017: $62.0K2018: $2.36M2019: $206.0K2020: $145.0K2021: $212.0K2022: $118.0K2023: $02024: $142.0K2025: $0$0
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$142.0K—
2023$0-100.0%
2022$118.0K-44.3%
2021$212.0K+46.2%
2020$145.0K-29.6%
2019$206.0K-91.3%
2018$2.36M+3711.3%
2017$62.0K-11.4%
2016$70.0K-95.1%
2015$1.42M-50.0%
2014$2.83M+4871.9%
2013$57.0K-52.9%
2012$121.0K-67.8%
2011$376.0K—